Population pharmacokinetics of piperacillin in critically ill children including those undergoing continuous kidney replacement therapy
Open Access
- 4 April 2022
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 28 (9) , 1287.e9-1287.e15
Abstract
No abstract availableKeywords
Funding Information
- Carlos III Health Institute
This publication has 24 references indexed in Scilit:
- Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill ChildrenAntimicrobial Agents and Chemotherapy, 2016
- Population Pharmacokinetics of Piperacillin in the Early Phase of Septic Shock: Does Standard Dosing Result in Therapeutic Plasma Concentrations?Antimicrobial Agents and Chemotherapy, 2015
- Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and ChildrenClinical Pharmacokinetics, 2015
- Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutionsThe Lancet Infectious Diseases, 2014
- Developmental Pharmacokinetics of Piperacillin and Tazobactam Using Plasma and Dried Blood Spots from InfantsAntimicrobial Agents and Chemotherapy, 2014
- Population Pharmacokinetics of Piperacillin/Tazobactam in Critically Ill Young ChildrenThe Pediatric Infectious Disease Journal, 2014
- DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?Clinical Infectious Diseases, 2014
- Population pharmacokinetics of piperacillin and tazobactam in critically ill patients undergoing continuous renal replacement therapy: application to pharmacokinetic/pharmacodynamic analysisJournal of Antimicrobial Chemotherapy, 2013
- Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapyCritical Care, 2011
- Automated Covariate Model Building Within NONMEMPharmaceutical Research, 1998